These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3048052)

  • 1. The Stockholm Diabetes Intervention Study (SDIS): 18 months' results.
    Reichard P; Britz A; Cars I; Nilsson BY; Sobocinsky-Olsson B; Rosenqvist U
    Acta Med Scand; 1988; 224(2):115-22. PubMed ID: 3048052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic control and complications over 3 years in patients with insulin dependent diabetes (IDDM): the Stockholm Diabetes Intervention Study (SDIS).
    Reichard P; Britz A; Carlsson P; Cars I; Lindblad L; Nilsson BY; Rosenqvist U
    J Intern Med; 1990 Nov; 228(5):511-7. PubMed ID: 2254723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years.
    Reichard P; Berglund B; Britz A; Cars I; Nilsson BY; Rosenqvist U
    J Intern Med; 1991 Aug; 230(2):101-8. PubMed ID: 1865159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications in IDDM are caused by elevated blood glucose level: the Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up.
    Reichard P; Pihl M; Rosenqvist U; Sule J
    Diabetologia; 1996 Dec; 39(12):1483-8. PubMed ID: 8960830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephropathy is delayed by intensified insulin treatment in patients with insulin-dependent diabetes mellitus and retinopathy.
    Reichard P; Rosenqvist U
    J Intern Med; 1989 Aug; 226(2):81-7. PubMed ID: 2671247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study.
    Reichard P; Pihl M
    Diabetes; 1994 Feb; 43(2):313-7. PubMed ID: 8288056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for progression of microvascular complications in the Stockholm Diabetes Intervention Study (SDIS).
    Reichard P
    Diabetes Res Clin Pract; 1992 May; 16(2):151-6. PubMed ID: 1600854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are there any glycemic thresholds for the serious microvascular diabetic complications?
    Reichard P
    J Diabetes Complications; 1995; 9(1):25-30. PubMed ID: 7734740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. Microalbuminuria Collaborative Study Group, United Kingdom.
    BMJ; 1995 Oct; 311(7011):973-7. PubMed ID: 7580637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term correction of hyperglycemia and progression of retinopathy in insulin dependent diabetes. A five-year randomized prospective study.
    Verrillo A; de Teresa A; Martino C; Verrillo L; di Chiara G
    Diabetes Res; 1988 Jun; 8(2):71-6. PubMed ID: 3067950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A 20-year prospective follow-up study to evaluate the development of retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory].
    Bolotskaya LL; Bessmertnaya EG; Shestakova MV; Shamkhalova MS; Nikankina LV; Ilyin AV; Glek IS; Zolotukhin AV; Dedov II
    Ter Arkh; 2017; 89(10):17-21. PubMed ID: 29171465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoglycaemic episodes during intensified insulin treatment: increased frequency but no effect on cognitive function.
    Reichard P; Berglund A; Britz A; Levander S; Rosenqvist U
    J Intern Med; 1991 Jan; 229(1):9-16. PubMed ID: 1995769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secondary prevention of diabetic retinopathy in type I diabetes mellitus. Dependence on retinopathy status before the intervention].
    Maca T; Fasching P; Rohac M; Stur M; Schneider B; Waldhäusl W
    Dtsch Med Wochenschr; 1996 Mar; 121(9):257-62. PubMed ID: 8681772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
    ; Nathan DM; Genuth S; Lachin J; Cleary P; Crofford O; Davis M; Rand L; Siebert C
    N Engl J Med; 1993 Sep; 329(14):977-86. PubMed ID: 8366922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years.
    Linkeschova R; Raoul M; Bott U; Berger M; Spraul M
    Diabet Med; 2002 Sep; 19(9):746-51. PubMed ID: 12207811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
    Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What glycemic control can be achieved in young diabetics without residual secretion of endogenous insulin? What is the frequency of severe hypoglycemia and subclinical complications?].
    Dorchy H
    Arch Pediatr; 1994 Nov; 1(11):970-81. PubMed ID: 7834046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HbA
    Lind M; Pivodic A; Svensson AM; Ólafsdóttir AF; Wedel H; Ludvigsson J
    BMJ; 2019 Aug; 366():l4894. PubMed ID: 31462492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.